Liver cancer docs to set up ace center in Xiangzhou

A cutting-edge cancer immunotherapy center and antigen bank for Chinese patients with liver cancer will be established in Xiangzhou District of Zhuhai, it was announced at a signing ceremony on Jan 24.

Zhuhai People's (Renmin) Hospital reached the agreement with an overseas Chinese team headed by Dr He You-Wen, professor of immunology with the Cell & Molecular Biology Program of Duke University. This contract inaugurates in Zhuhai research and development of tailored precision therapeutic arrangements for tumor-infiltrating T cells.

Dr He's researchers have developed a series of technical platforms for cellular therapy at labs at Duke and Peking Union Medical College (PUMC). They study T cell biology in health and disease, and also investigate T lymphocyte-mediated anti-cancer immunity and the intracellular process termed autophagy in T lymphocyte function.

Collaborating are research teams of Professor Li Shiyou at the Beijing Institute of Genomics of the Chinese Academy of Sciences.

Based on their efforts, individualized immunotherapy will be utilized for each case and endeavors will be made to set up clinical treatment standards and industry norms, according to the agreement.

Signing ceremony [Photo provided by Zhuhai People's Hospital]

The move is expected to enhance regional medical treatment and serve the Guangdong-Hong Kong-Macao Greater Bay Area and even the country, claimed a spokesperson.

Dr He received his medical degree from the Fourth Military Medical University in Xi'an in Shaanxi Province, PhD from the University of Miami, and is a Senior Fellow of Immunology at the University of Washington, and Changjiang (Yangtze River) Scholar Chaired Professor. Duke University is located in Durham, North Carolina.